You are here

Annidis Attends First Major Ophthalmology Conference in China

Share This Page:  
Thursday, March 6, 2014


Annidis Multi-Spectral Imaging technology was presented for the first time at a major ophthalmology conference in China, focused on retina specialists. The conference took place in the city of Dalian, Province of Liaoning, China from February 28 to March 1, 2014. The key presenter, Dr. Li Xiaoxin is a Professor and Chairperson for People’s Eye Center at People’s Hospital of Peking University, President of the Asia-Pacific Vitreoretina Society and a Chairperson of the Chinese Ocular Fundus Diseases Society. Dr. Li utilizes the Annidis RHATM instrument in her hospital for clinical research and her presentation was focused on several patient cases, including RPE tears, cancer-associated retinopathy (CAR) and autoimmune-associated retinopathy (AAR).

During the presentation, Dr. Li introduced Multi-Spectral Imaging and indicated that “RHA provides more details in several retinal diseases”. She also stated that “RHA is more sensitive to imaging RPE than any other imaging modality including Fundus photography, OCT, AF, IVFA.”

Dr. Li’s presentation was attended by more than one thousand leading retina specialists and key opinion leaders in China. A short video clip from her presentation can be found at here.

Following the presentation, retina specialists and other congress participants were able to visit the SZNIMO booth, the exclusive distributors of Annidis RHATM imaging systems in China. At the SZNIMO booth, leading retinal specialists were able to experience how the technology works, discuss in detail its potential applications and the diagnostic advantages of Annidis MSI technology.

Professor Zhang from West China hospital said that, “Oxy/Deoxygen map sets up a new path to assess retina and choroid. It's a new standard."  

Annidis and SZNIMO are now collaborating through clinical studies with half a dozen major hospitals in China.  Professor Chen from Peking Union Medical College Hospital spent time at the booth and commented after reviewing technology that, "Maybe we have found a new way to diagnose Polypoidal Choroidal Vasculopathy (PCV), but it's non-invasive." For more details about the tradeshow visit  

Annidis President Nick Ribaric, who attended the meeting said that, “The energy and enthusiasm for the potential of Annidis Multi-Spectral Imaging, by retina specialists who visited the booth, was beyond my expectations. We really look forward to the annual Ophthalmology conference in September 2014.”